Risk of HBV reactivation during therapies for HCC: A systematic review

Papatheodoridi, M; Tampaki, M; Lok, AS; Papatheodoridis, GV

Papatheodoridis, GV (通讯作者)，Natl & Kapodistrian Univ Athens, Gen Hosp Athens Laiko, Med Sch, Dept Gastroenterol, Athens, Greece.;Papatheodoridis, GV (通讯作者)，Natl & Kapodistrian Univ Athens, Gen Hosp Athens Laiko, Med Sch, Liver Transplantat Unit, Athens, Greece.;Lok, AS (通讯作者)，Univ Michigan, Div Gastroenterol & Hepatol, 1500 East Med Ctr Dr,3912 Taubman Ctr,SPC 5362, Ann Arbor, MI 48109 USA.

HEPATOLOGY, 2022; 75 (5): 1257

Abstract

Background and Aims Treatment for HCC has evolved rapidly, but the risk of HBV reactivation to new therapies is unclear. We systematically reviewed da......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索